AYTU BIOPHARMA, INC Quarterly Common Stock, Shares, Issued from Q3 2011 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Aytu Biopharma, Inc quarterly Common Stock, Shares, Issued history and growth rate from Q3 2011 to Q2 2024.
  • Aytu Biopharma, Inc Common Stock, Shares, Issued for the quarter ending June 30, 2024 was 5.97M shares, a 8.26% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 5.97M +455K +8.26% Jun 30, 2024 10-K 2024-09-26
Q1 2024 5.57M +1.79M +47.3% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 5.57M +2.18M +64.6% Dec 31, 2023 10-Q 2024-02-14
Q3 2023 5.53M +2.41M +77.2% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 5.52M +3.59M +186% Jun 30, 2023 10-K 2024-09-26
Q1 2023 3.78M -29.6M -88.7% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 3.38M -26.6M -88.7% Dec 31, 2022 10-Q 2023-02-21
Q3 2022 3.12M -24.7M -88.8% Sep 30, 2022 10-Q/A 2023-02-21
Q2 2022 1.93M -25.6M -93% Jun 30, 2022 10-K 2023-10-12
Q1 2022 33.4M +9.9M +42.2% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 30M +12.1M +67.8% Dec 31, 2021 10-Q 2022-02-14
Q3 2021 27.8M -98.1M -77.9% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 27.5M +14.9M +118% Jun 30, 2021 10-K 2022-09-27
Q1 2021 23.5M -77.2M -76.7% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 17.9M -2.85M -13.7% Dec 31, 2020 10-Q 2021-02-11
Q3 2020 126M +108M +600% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 12.6M -4.95M -28.2% Jun 30, 2020 10-K 2021-09-28
Q1 2020 101M +87.8M +683% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 20.7M +10.2M +97.4% Dec 31, 2019 10-Q 2020-02-14
Q3 2019 18M +16.2M +898% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 17.5M +15.7M +877% Jun 30, 2019 10-K 2020-10-06
Q1 2019 12.8M -23M -64.1% Mar 31, 2019 10-Q 2019-05-14
Q4 2018 10.5M +5.61M +115% Dec 31, 2018 10-Q/A 2019-05-14
Q3 2018 1.8M -2.42M -57.4% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 1.79M +1.75M +4252% Jun 30, 2018 10-K 2019-09-26
Q1 2018 35.8M +22M +159% Mar 31, 2018 10-Q 2018-05-14
Q4 2017 4.89M -5.95M -54.9% Dec 31, 2017 10-Q 2018-02-08
Q3 2017 4.22M -886K -17.3% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 41.2K -146K -78% Jun 30, 2017 10-K 2018-09-06
Q1 2017 13.8M -8.61M -38.4% Mar 31, 2017 10-Q 2017-05-11
Q4 2016 10.8M -3.41M -23.9% Dec 31, 2016 10-Q 2017-02-09
Q3 2016 5.11M -9.15M -64.2% Sep 30, 2016 10-Q 2016-11-07
Q2 2016 187K -1M -84.3% Jun 30, 2016 10-K 2017-08-31
Q1 2016 22.4M +16.6M +285% Mar 31, 2016 10-Q 2016-05-11
Q4 2015 14.3M +8.42M +144% Dec 31, 2015 10-Q 2016-02-11
Q3 2015 14.3M +8.52M +149% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 1.19M -6.71M -85% Jun 30, 2015 10-K 2016-09-01
Q1 2015 5.84M +918K +18.7% Feb 28, 2015 10-Q 2015-04-15
Q4 2014 5.84M +918K +18.7% Nov 30, 2014 10-Q 2015-01-12
Q3 2014 5.74M +838K +17.1% Aug 31, 2014 10-Q 2015-04-15
Q2 2014 7.9M +3.01M +61.6% Jun 30, 2014 10-K 2015-09-30
Q1 2014 4.92M +28K +0.57% Feb 28, 2014 10-Q 2014-04-11
Q4 2013 4.92M +28K +0.57% Nov 30, 2013 10-Q 2014-01-10
Q3 2013 4.9M +41.3K +0.85% Aug 31, 2013 10-K 2014-11-26
Q2 2013 4.89M +74.8K +1.55% May 31, 2013 10-Q 2013-06-28
Q1 2013 4.89M +74.8K +1.55% Feb 28, 2013 10-Q 2013-04-15
Q4 2012 4.89M +115K +2.41% Nov 30, 2012 10-Q 2013-01-14
Q3 2012 4.86M +121K +2.56% Aug 31, 2012 10-K 2014-11-26
Q2 2012 4.81M May 31, 2012 10-Q 2012-06-26
Q1 2012 4.81M Feb 29, 2012 10-Q 2012-04-12
Q4 2011 4.77M Nov 30, 2011 10-Q 2011-12-23
Q3 2011 4.73M Aug 31, 2011 10-K 2012-11-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.